Cited by 198Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsDendrimers and Hyperbranched Polymers

Enhancing tumor penetration of nanomedicines

Open access
Sun, Qingxue, Ojha, Tarun, Kiessling, Fabian, Lammers, Twan, Shi, Yang·2017·Biomacromolecules

Abstract

Tumor-targeted nanomedicines have been extensively applied to alter the drawbacks and enhance the efficacy of chemotherapeutics. Despite the large number of preclinical nanomedicine studies showing initial success, their therapeutic benefit in the clinic has been rather modest, which is partially due to the inefficient tumor penetration caused by the tumor microenvironment (high density of cells and extracellular matrix, increased interstitial fluid pressure). Furthermore, tumor penetration of nanomedicines is significantly influenced by physicochemical characteristics, such as size, surface chemistry, and shape. The effect of size on tumor penetration has been exploited to design nanomedicines with switchable size to tackle this challenge. Moreover, several pharmacological and physical approaches have been developed to enhance the tumor penetration of nanomedicines, by penetration-promoting ligands, intratumoral drug release, and modulating the tumor microenvironment and vasculature. Overall, these efforts have resulted in nanomedicines with better tumor penetration properties and with enhanced therapeutic efficacy. Future research should be directed to penetration-promoting strategies with broad applicability and with high translational potential.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.biomac.7b00068

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 4

  1. [18]Campbell RB Fukumura D Brown EB Mazzola LM Izumi Y Jain RK Torchilin VP Munn LL Cancer Res 2002 62 6831 6836 12460895
  2. [45]Fujimori K Covell DG Fletcher JE Weinstein JN Cancer Res 1989 49 5656 5663 2790783
  3. [65]Goodman TT Olive PL Pun SH Int J Nanomed 2007 2 265 274 PMC2673974 17722554
  4. [70]Tozer GM Prise VE Wilson J Cemazar M Shan S Dewhirst MW Barber PR Vojnovic B Chaplin DJ Cancer Res 2001 61 6413 6422 11522635

Cited by

Sorted by citations

Authors
Sun, Q., Ojha, T., Kiessling, F., Lammers, T., & Shi, Y.
Affiliations
  • Universitätsklinikum Aachen (DE)
  • Utrecht University (NL)
Corresponding author
Shi, Yang
Venue
Biomacromolecules
Published
2017-03-31
Volume
18
Issue
5
Pages
1449-1459
ISSN
  • 1525-7797 (ISSN-L)
  • 1526-4602
OpenAlex
W2600801958
Cited by
198
References
92
Citations by year
2026: 8 · 2025: 14 · 2024: 14 · 2023: 10 · 2022: 25 · 2021: 21 · 2020: 36 · 2019: 37 · 2018: 24 · 2017: 9
FWCI
2.10
Type
journal article
Language
en
Open access
Locations
  • Biomacromolecules (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • University of Twente Research Information (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (La2937/1-2)
  • H2020 European Research Council (309495, 642028, 680882)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
tumor penetration, nanomedicine, tumor microenvironment, interstitial fluid pressure, extracellular matrix, nanoparticle size, surface chemistry, nanoparticle morphology, anticancer drug delivery
MeSH terms
Animals, Antineoplastic Agents, Humans, Neoplasms, Nanomedicine, Nanoparticles, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review